Zydus Cadila gets USFDA approval to market generic version of Deferasirox tablets

Zydus Cadila, part of Cadila Healthcare group, on Tuesday said it has
received final approval from the US health regulator to market its
generic version of Deferasirox tablets used in treatment of chronic
iron overload due to blood transfusions.

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/zydus-cadila-gets-usfda-approval-to-market-generic-version-of-deferasirox-tablets/articleshow/76399918.cms

Comments

Popular posts from this blog

Pharma Production Executive Post Vacancy @ Intas

Pharos of Chaos

HILR Intersession: Mollie Crawford-Volk: Velazquez' "Las Meninas" and its Modern Progeny